| 1 | Nature Reviews Drug Discovery | 159.2 | 99th | Q1 | SCIE | – | No |
| 2 | Medicinal Research Reviews | 29.1 | 99th | Q1 | SCIE | – | No |
| 3 | Protein and Cell | 22.6 | 98th | Q1 | SCIE | – | Yes |
| 4 | Natural Product Reports | 21.2 | 97th | Q1 | SCIE | – | No |
| 5 | Molecular Therapy | 17.9 | 97th | Q1 | SCIE | – | No |
| 6 | Drug Discovery Today | 16.8 | 96th | Q1 | SCIE | – | No |
| 7 | Emerging Microbes and Infections | 14.1 | 95th | Q1 | SCIE | – | Yes |
| 8 | Archives of Pharmacal Research | 13.6 | 95th | Q1 | SCIE | – | No |
| 9 | Cell Chemical Biology | 13.6 | 94th | Q1 | SCIE | – | No |
| 10 | Phytomedicine | 13.2 | 94th | Q1 | SCIE | – | No |
| 11 | MedComm | 12.5 | 93th | Q1 | ESCI | – | Yes |
| 12 | Pharmaceutical Biology | 12.4 | 92th | Q1 | SCIE | – | Yes |
| 13 | Current Opinion in Pharmacology | 12.2 | 92th | Q1 | SCIE | – | No |
| 14 | Journal of Pharmaceutical Analysis | 12 | 91th | Q1 | SCIE | – | Yes |
| 15 | Journal of Enzyme Inhibition and Medicinal Chemistry | 11.9 | 90th | Q1 | SCIE | – | Yes |
| 16 | NEJM Evidence | 11.7 | 90th | Q1 | ESCI | – | No |
| 17 | Marine Drugs | 11.6 | 89th | Q1 | SCIE | – | Yes |
| 18 | Medicine in Drug Discovery | 11.5 | 89th | Q1 | – | – | Yes |
| 19 | Nucleic Acid Therapeutics | 11.4 | 88th | Q1 | SCIE | – | No |
| 20 | EPMA Journal | 11.4 | 87th | Q1 | SCIE | – | No |
| 21 | Journal of Ethnopharmacology | 11.2 | 87th | Q1 | SCIE | – | No |
| 22 | Journal of Medicinal Chemistry | 11.1 | 86th | Q1 | SCIE | – | No |
| 23 | Molecular Therapy Nucleic Acids | 10.8 | 86th | Q1 | SCIE | – | Yes |
| 24 | European Journal of Medicinal Chemistry | 10.8 | 85th | Q1 | SCIE | – | No |
| 25 | International Journal of Nanomedicine | 10.6 | 84th | Q1 | SCIE | – | Yes |
| 26 | Molecules | 10.3 | 84th | Q1 | SCIE | – | Yes |
| 27 | Expert Opinion on Drug Discovery | 9.9 | 83th | Q1 | SCIE | – | No |
| 28 | Expert Review of Vaccines | 9.9 | 82th | Q1 | SCIE | – | Yes |
| 29 | Pharmaceuticals | 9 | 82th | Q1 | SCIE | – | Yes |
| 30 | Biotechnology and Applied Biochemistry | 8.9 | 81th | Q1 | SCIE | – | No |
| 31 | Expert Opinion on Therapeutic Targets | 8.6 | 81th | Q1 | SCIE | – | No |
| 32 | Journal of Molecular Medicine | 8.6 | 80th | Q1 | SCIE | – | No |
| 33 | EXCLI Journal | 8.6 | 79th | Q1 | SCIE | – | Yes |
| 34 | Expert Opinion on Therapeutic Patents | 8.3 | 79th | Q1 | SCIE | – | No |
| 35 | Molecular Diversity | 7.9 | 78th | Q1 | SCIE | – | No |
| 36 | Current Molecular Pharmacology | 7.8 | 77th | Q1 | SCIE | – | No |
| 37 | PPAR Research | 7.8 | 77th | Q1 | SCIE | – | Yes |
| 38 | Chinese Journal of Natural Medicines | 7.7 | 76th | Q1 | SCIE | – | No |
| 39 | Vaccines | 7.7 | 76th | Q1 | SCIE | – | Yes |
| 40 | Molecular Pharmaceutics | 7.6 | 75th | Q1 | SCIE | – | No |
| 41 | ACS Bio and Med Chem Au | 7.5 | 74th | Q2 | ESCI | – | Yes |
| 42 | Mini-Reviews in Medicinal Chemistry | 7.5 | 74th | Q2 | SCIE | – | No |
| 43 | Journal of Applied Research on Medicinal and Aromatic Plants | 7.4 | 73th | Q2 | SCIE | – | No |
| 44 | Open Medicinal Chemistry Journal | 7.3 | 72th | Q2 | – | – | No |
| 45 | Drug Development Research | 7 | 72th | Q2 | SCIE | – | No |
| 46 | Bioorganic Chemistry | 6.9 | 71th | Q2 | SCIE | – | No |
| 47 | Drug Design, Development and Therapy | 6.9 | 71th | Q2 | SCIE | – | Yes |
| 48 | Molecular Informatics | 6.8 | 70th | Q2 | SCIE | – | No |
| 49 | Current Gene Therapy | 6.7 | 69th | Q2 | SCIE | – | No |
| 50 | Current Topics in Medicinal Chemistry | 6.6 | 69th | Q2 | SCIE | – | No |
| 51 | Expert Opinion on Biological Therapy | 6.5 | 68th | Q2 | SCIE | – | No |
| 52 | Journal of Pharmaceutical and Biomedical Analysis | 6.5 | 68th | Q2 | SCIE | – | No |
| 53 | Archiv der Pharmazie | 6.5 | 67th | Q2 | SCIE | – | No |
| 54 | Current Medicinal Chemistry | 6.5 | 66th | Q2 | SCIE | – | No |
| 55 | Biomolecules and Therapeutics | 6.4 | 66th | Q2 | SCIE | – | No |
| 56 | Human Genomics | 6.4 | 65th | Q2 | SCIE | – | Yes |
| 57 | Journal of Natural Products | 6.3 | 64th | Q2 | SCIE | – | No |
| 58 | Chemical Biology and Drug Design | 6.1 | 64th | Q2 | SCIE | – | No |
| 59 | Current Drug Targets | 6 | 63th | Q2 | SCIE | – | No |
| 60 | Therapeutic Advances in Vaccines and Immunotherapy | 6 | 63th | Q2 | – | – | Yes |
| 61 | Chirality | 5.9 | 62th | Q2 | SCIE | – | No |
| 62 | Current Pharmaceutical Design | 5.8 | 61th | Q2 | SCIE | – | No |
| 63 | Journal of the Indian Chemical Society | 5.8 | 61th | Q2 | SCIE | – | No |
| 64 | ChemMedChem | 5.7 | 60th | Q2 | SCIE | – | No |
| 65 | RSC Medicinal Chemistry | 5.7 | 59th | Q2 | SCIE | – | No |
| 66 | Recent Patents on Anti-Cancer Drug Discovery | 5.6 | 59th | Q2 | SCIE | – | No |
| 67 | ACS Medicinal Chemistry Letters | 5.6 | 58th | Q2 | SCIE | – | No |
| 68 | Bioorganic and Medicinal Chemistry | 5.6 | 58th | Q2 | SCIE | – | No |
| 69 | International Journal of Peptide Research and Therapeutics | 5.3 | 57th | Q2 | SCIE | – | No |
| 70 | Iranian Journal of Basic Medical Sciences | 5.2 | 56th | Q2 | SCIE | – | Yes |
| 71 | Journal of Natural Medicines | 5.2 | 56th | Q2 | SCIE | – | No |
| 72 | Phytochemical Analysis | 5.2 | 55th | Q2 | SCIE | – | No |
| 73 | Frontiers in Antibiotics | 5 | 54th | Q2 | ESCI | – | Yes |
| 74 | Frontiers in Drug Discovery | 5 | 54th | Q2 | ESCI | – | Yes |
| 75 | Current Opinion in Systems Biology | 5 | 53th | Q2 | ESCI | – | No |
| 76 | Medicinal Chemistry | 5 | 53th | Q2 | SCIE | – | No |
| 77 | Antibodies | 4.9 | 52th | Q2 | ESCI | – | Yes |
| 78 | International Journal of Cosmetic Science | 4.8 | 51th | Q2 | SCIE | – | No |
| 79 | Journal of Gene Medicine | 4.8 | 51th | Q2 | SCIE | – | No |
| 80 | DARU, Journal of Pharmaceutical Sciences | 4.8 | 50th | Q2 | SCIE | – | No |
| 81 | Journal of Basic and Clinical Physiology and Pharmacology | 4.7 | 50th | Q2 | – | – | No |
| 82 | npj Systems Biology and Applications | 4.7 | 49th | Q3 | SCIE | – | Yes |
| 83 | Planta Medica | 4.7 | 48th | Q3 | SCIE | – | No |
| 84 | Journal of Antibiotics | 4.6 | 48th | Q3 | SCIE | – | No |
| 85 | Current Pharmacology Reports | 4.6 | 47th | Q3 | ESCI | – | No |
| 86 | Drug Research | 4.6 | 46th | Q3 | ESCI | – | No |
| 87 | Journal of Computer-Aided Molecular Design | 4.6 | 46th | Q3 | SCIE | – | No |
| 88 | Bioorganic and Medicinal Chemistry Letters | 4.5 | 45th | Q3 | SCIE | – | No |
| 89 | SAR and QSAR in Environmental Research | 4.4 | 45th | Q3 | SCIE | – | No |
| 90 | Cancer Innovation | 4.4 | 44th | Q3 | ESCI | – | Yes |
| 91 | Future Medicinal Chemistry | 4.4 | 43th | Q3 | SCIE | – | No |
| 92 | Avicenna Journal of Phytomedicine | 4.3 | 43th | Q3 | ESCI | – | Yes |
| 93 | Journal of Medicinal and Chemical Sciences | 4.3 | 42th | Q3 | – | – | No |
| 94 | Current Cancer Drug Targets | 4.2 | 41th | Q3 | SCIE | – | No |
| 95 | Journal of Ayurveda and Integrative Medicine | 4.2 | 41th | Q3 | ESCI | – | Yes |
| 96 | Medinformatics | 4 | 40th | Q3 | – | – | No |
| 97 | Fitoterapia | 3.9 | 40th | Q3 | SCIE | – | No |
| 98 | Studies in Natural Products Chemistry | 3.9 | 39th | Q3 | – | – | No |
| 99 | Assay and Drug Development Technologies | 3.8 | 38th | Q3 | SCIE | – | No |
| 100 | Journal of Peptide Science | 3.8 | 38th | Q3 | SCIE | – | No |